BCA
APDNW

Benchmark Capital Advisors’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History

Benchmark Capital Advisors’s Portfolio APDNW Stock Details APDNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,000
Closed -$8K – 130
2016
Q4 		$8K Hold
16,000
– – 0.01% 125
2016
Q3 		$18K Hold
16,000
– – 0.01% 128
2016
Q2 		$18K Hold
16,000
– – 0.01% 126
2016
Q1 		$29K Buy
16,000
+6,000
+60% +$8.36K 0.03% 120
2015
Q4 		$17K Buy
+10,000
New +$25.4K 0.01% 117

Other funds holding APDNW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Benchmark Capital Advisors's APDNW Position: Q1 2017 in Review

Benchmark Capital Advisors sold out of Applied DNA Sciences Inc Warrant (APDNW) in Q1 2017, closing a stake of 16,000 shares — an estimated $8K sold.

Benchmark Capital Advisors first reported a position in APDNW in Q4 2015 and held it in 5 quarters. The position peaked at $29K in Q1 2016. 7 funds tracked by Wall St. Rank hold APDNW as of Q1 2017.

  • Benchmark Capital Advisors reported no remaining Applied DNA Sciences Inc Warrant position as of Q1 2017 after selling out during the quarter.
  • Benchmark Capital Advisors sold 16,000 Applied DNA Sciences Inc Warrant shares in Q1 2017, an estimated $8K.
  • Benchmark Capital Advisors first reported a position in Applied DNA Sciences Inc Warrant in Q4 2015 and held it in 5 quarters.
  • Benchmark Capital Advisors's Applied DNA Sciences Inc Warrant position peaked at $29K in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q1 2017.

Based on Benchmark Capital Advisors's 13F filing for Q1 2017, filed 9 May 2017.